Direct-to-consumer advertising and the demand for cholesterol-reducing drugs

Journal of Law and Economics

Volumn 45, Issue 2 II, 2002, Pages 673-690

  Calfee, John E ^a   Winston, Clifford ^a   Stempski, Randolph ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042634107     PISSN: 00222186     EISSN: None     Source Type: Journal    
DOI: 10.1086/374704     Document Type: Conference Paper

References (43)

1. Adams, Chris. "FDA Plans to Review Policy Allowing Direct-to-Consumer Drug Ads for TV." Wall Street Journal, March 28, 2001, p. B1.
2. Azoulay, Pierre. "Do Pharmaceutical Sales Respond to Scientific Evidence? Evidence from Anti-ulcer Drugs." Journal of Economics and Management Strategy 11 (2002): 551-94.
3. Benham, Lee. "The Effect of Advertising on the Price of Eyeglasses." Journal of Law and Economics 15 (1972): 337-52.
4. Calfee, John E. "Public Policy Issues in Direct-to-Consumer Advertising of Prescription Drugs." Journal of Public Policy and Marketing 19 (2002): 174-94.
5. Calfee, John E., and Glassman, James K. Fear of Persuasion: A New Perspective on Advertising and Regulation. London: Agora; North American distribution by the American Enterprise Institute, 1997.
6. Cleeman, James I., and Lenfant, Claude. "The National Cholesterol Education Program: Progress and Prospects." Journal of the American Medical Association 280 (1998): 2099-2104.
7. Dubois, Robert W., et al. "Growth in Use of Lipid Lowering Therapies: Bad News? Good News? Or the Wrong Question?" Unpublished manuscript. Santa Monica, Cal.: Protocare Sciences, Inc., 2001.
8. Ellickson, Paul; Stern, Scott; and Trajtenberg, Manuel. "Patient Welfare and Patient Compliance: An Empirical Framework for Measuring the Benefits from Pharmaceutical Innovation." Working Paper No. 6890. Cambridge, Mass.: National Bureau of Economic Research, 1999.
9. Elliott, Victoria Stagg. "FDA Advisory Committee Vetoes OTC Status for Low-Dose Anti-cholesterol Drugs." American Medical News, August 7, 2000. http://www.ama-assn.org/sci-pubs/amnews/pick_00/hlsb0807.htm.
10. Elliott, Victoria Stagg. "Questions Swirl around Drug Ads for Patients." American Medical News, July 9/16, 2001. http://www.ama-assn.org/sci-pubs/amnews/pick_01/hl10709.htm.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. "Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)." Journal of the American Medical Association 285 (2001): 2486-97.
12. Federal Trade Commission. Bureau of Consumer Protection and Bureau of Economics. "In the Matter of Direct-to-Consumer Promotion." No. 95N-0227. Washington, D.C.: Federal Trade Commission, January 11, 1996. http://www.ftc.gov/be/v960001.htm.
13. Federal Trade Commission. Bureau of Economics, Bureau of Consumer Protection, and Office of Policy Planning. "In the Matter of Request for Comment on First Amendment Issues." No. 02N-0209. Washington, D.C.: Federal Trade Commission, September 13, 2002. http://ftc.gov/os/2002/09/fdatextversion.pdf.
14. Fonarow, Gregg C., et al. "Use of Lipid-Lowering Medications at Discharge in Patients with Acute Myocardial Infarction: Data from the National Registry of Myocardial Infarction." Circulation 103 (2001): 38-44.
15. Food and Drug Administration. Center for Drug Evaluation and Research. "Draft Guidance for Industry on Consumer-Directed Broadcast Advertisements" (No. 97D-0302, July 1997). Federal Register 62 (1997): 43171-43173.
16. Food and Drug Administration. Center for Drug Evaluation and Research. "Guidance for Industry on Consumer-Directed Broadcast Advertisements" (No. 97D-0302, August 1999). Federal Register 64 (1999): 43197-43198.
17. Food and Drug Administration. Center for Drug Evaluation and Research. From Test Tube to Patient: Improving Health through Human Drugs. Rockville, Md.: Center for Drug Evaluation and Research, September 1999.
18. Hollon, Matthew F. "Direct-to-Consumer Marketing of Prescription Drugs: Creating Consumer Demand." Journal of the American Medical Association 281 (1999): 382-84.
19. Ippolito, Pauline M., and Mathios, Alan D. "Information, Advertising and Health Choices: A Study of the Cereal Market." Rand Journal of Economics 21 (1990): 459-80.
20. Ippolito, Pauline M., and Mathios, Alan D. "Information, Policy, and the Sources of Fat and Cholesterol in the U.S. Diet." Journal of Public Policy and Marketing 13 (1994): 200-217.
21. Katan, Martijn B. "Review of D. John Betteridge, ed., Lipids: Current Perspectives." New England Journal of Medicine 336 (1997): 1394.
22. Kwoka, John E., Jr. "Advertising and Price and Quality of Optometric Services." American Economic Review 74 (1984): 211-16.
23. Landers, Susan J. "Beyond Cholesterol: New Uses for Stalins." American Medical News, June 18, 2001. http://www.ama-assn.org/sci-pubs/amnews/pick_01/hlsb0618.htm.
24. Mannering, Fred, and Winston, Clifford. "Automobile Air Bags in the 1990s: Market Failure or Market Efficiency?" Journal of Law and Economics 38 (1995): 265-79.
25. Monkman, D. "Treating Dyslipidaemia in Primary Care: The Gap between Policy and Reality Is Large in the U.K." British Medical Journal 321 (2000): 1299-1300.
26. Morris, Louis A., and Millstein, Lloyd G. "Drug Advertising to Consumers: Effects of Formats for Magazine and Television Advertisements." Food Drug Cosmetic Law Journal 39 (1984): 497-503.
27. National Health Council. "Statement: Direct-to-Consumer Prescription Drug Advertising." January 2002. http://www.nationalhealthcouncil.org/advocacy/dtc.htm, accessed September 29, 2002.
28. National Health Council. "Direct-to-Consumer Prescription Drug Advertising: Overview and Recommendations." January 2002. http://www.nationalhealthcouncil.org/advocacy/DTC_paper.pdf, accessed June 30, 2002.
29. National Institutes of Health. National Cholesterol Education Program. "Recommendations on Lipoprotein Measurement: From the Working Group on Lipoprotein Measurement." Publication No. 95-3044. Washington, D.C.: National Institutes of Health, 2001. http://www.fchn.org/fmh/wmchh/guidelines/lipoprot.pdf.
30. Pallarito, Karen. "States Target Direct-to-Consumer Drug Ads." Reuters Health, June 28, 2001.
31. Pharmaceutical Research and Manufacturers of America. Pharmaceutical Industry Profile 1999. Washington, D.C.: Pharmaceutical Research and Manufacturers of America, 1999.
32. Pines, Wayne L. "A History and Perspective on Direct-to-Consumer Promotion." Food and Drug Law Journal 54 (1999): 489-518.
33. Pitt, Bertram, et al. (for the Atorvastatin versus Revascularization Treatment Investigators). "Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease." New England Journal of Medicine 341 (1999): 70-76.
34. Reissman, Debi L. "Issues in Drug Benefit Management: Back to Compliance." Drug Benefit Trends 10 (1998): 18.
35. Roberts, William C. "Twenty Questions on Atherosclerosis." Baylor University Medical Center Proceedings 13 (2000): 139-43.
36. Rosenthal, Meredith B., et al. "Demand Effects of Recent Changes in Prescription Drug Promotion." Working paper. Cambridge, Mass.: National Bureau of Economic Research, June 28, 2002. http://www.nber.org/books/gerber6/rosenthal-et-al7-1-02.pdf.
37. Ross, Susan D., et al. "Clinical Outcomes in Statin Treatment Trials." Archives of Internal Medicine 159 (1999): 11793-802.
38. Safeer, Richard S., and LaCivita, Cynthia L. "Choosing Drug Therapy for Patients with Hyperlipidemia." American Family Physician 61 (2000): 3371-82.
39. Slaughter, Ed, and Schumacher, Martha. "International Survey on Wellness and Consumer Reactions to DTC Advertising of Rx Drugs." Prevention Magazine (2002).
40. Tang, J. L., et al. "Systematic Review of Dietary Intervention Trials to Lower Blood Total Cholesterol in Free-Living Subjects." British Medical Journal 316 (1998): 1213-20.
41. Taubes, Gary. "The Soft Science of Dietary Fat." Science 291 (2001): 2536-45.
42. White, Harvey D., et al. "Pravastatin Therapy and the Risk of Stroke." New England Journal of Medicine 343 (2000): 317-26.
43. Wosinska, Marta. "Effects of Direct-to-Consumer Drug Advertising on Prescription Choice." Working paper. Berkeley: University of California, Berkeley, Department of Economics, 2001.